5-Methylquinoxaline

Suppliers

Names

[ CAS No. ]:
13708-12-8

[ Name ]:
5-Methylquinoxaline

[Synonym ]:
5-methyl quinoxaline
5-Methylquinoxaline
8-methylquinoxoline
8-methylquinoxaline
T66 BN ENJ G1
Quinoxaline,5-methyl
EINECS 237-246-5
Quinoxaline, 5-methyl-
MFCD00012335
5-Methyl-chinoxalin

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
244.8±0.0 °C at 760 mmHg

[ Melting Point ]:
20-21 °C(lit.)

[ Molecular Formula ]:
C9H8N2

[ Molecular Weight ]:
144.173

[ Flash Point ]:
108.8±13.1 °C

[ Exact Mass ]:
144.068741

[ PSA ]:
25.78000

[ LogP ]:
1.76

[ Vapour Pressure ]:
0.0±0.4 mmHg at 25°C

[ Index of Refraction ]:
1.633

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter

[ Hazard Codes ]:
Xi: Irritant;

[ Risk Phrases ]:
R36/37/38

[ Safety Phrases ]:
S26

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2933990090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • 2,3-diaminotoluene
  • 5-methyl-1,2,3,4-tetrahydroquinoxaline
  • 2-Methyl-6-nitroaniline
  • 5-(2,6-dimethylphenyl)-1-phenyl-1H-1,2,5-triazapentadiene
  • GLYOXAL SODIUM BISULFITE

DownStream

  • 5-(Bromomethyl)quinoxaline
  • 5-Quinoxalinecarbaldehyde
  • 5-(Dibromomethyl)quinoxaline

Customs

[ HS Code ]: 2933990090

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

Inhibitory effect of herbal medicines and their trapping abilities against methylglyoxal-derived advanced glycation end-products.

BMC Complement Altern. Med. 15 , 394, (2015)

Methylglyoxal (MG) is one of the most reactive glycating agents, which result the formation of advanced glycation end-products (AGEs) that have been implicated in the progression of age-related diseas...


More Articles

Related Compounds

  • 2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-methylselanyl-3H-purin-6-one
  • 5,6,7,8-tetrahydro-5-methyl quinoxaline
  • 5-methyl-2H-[1,2,4]triazolo[4,3-a]quinoxaline-1,4-dione
  • 5-methyl-7,8-diphenyl-[1,2,5]thiadiazolo[3,4-f]quinoxaline
  • 5-Methyl-7-trifluoromethyl-2H,5H-[1,2,4]triazolo[4,3-a]quinoxaline-1,4-dione
  • 5-methyl-2,4-diphenyl-1,4,4a,5,10,10a-hexahydro-1,3,4-thiadiazino<5,6-b>quinoxaline
  • (3R)-1-amino-5-[methyl(propan-2-yl)amino]pentan-3-ol
  • 4-[(3R)-3-hydroxybutyl]-3-methoxyphenol
  • (2S)-1-(5-methylfuran-2-yl)propan-2-ol
  • 5-iodo-1-(3-methoxypropyl)-1H-1,2,3-benzotriazole
  • (2R)-4-[2-fluoro-5-(trifluoromethyl)phenyl]butan-2-amine
  • O-[2-methyl-2-(oxolan-2-yl)propyl]hydroxylamine
  • 2-[1-(Butan-2-yl)cyclopropyl]ethan-1-amine
  • (2S)-1-(3-methyloxetan-3-yl)propan-2-ol
  • 1-[4-(Aminomethyl)oxan-4-yl]-3-fluoropropan-2-ol
  • 5-iodo-1-[2-(methylsulfanyl)ethyl]-1H-1,2,3-benzotriazole
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.